Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Biol ; 42(1): e0046721, 2022 01 20.
Article in English | MEDLINE | ID: mdl-34723652

ABSTRACT

A subset of hospitalized COVID-19 patients, particularly the aged and those with comorbidities, develop the most severe form of the disease, characterized by acute respiratory disease syndrome (ARDS), coincident with experiencing a "cytokine storm." Here, we demonstrate that cytokines which activate the NF-κB pathway can induce activin A. Patients with elevated activin A, activin B, and FLRG at hospital admission were associated with the most severe outcomes of COVID-19, including the requirement for mechanical ventilation, and all-cause mortality. A prior study showed that activin A could decrease viral load, which indicated there might be a risk to giving COVID-19 patients an inhibitor of activin. To evaluate this, the role for activin A was examined in a hamster model of SARS-CoV-2 infection, via blockade of activin A signaling. The hamster model demonstrated that use of an anti-activin A antibody did not worsen the disease and there was no evidence for increase in lung viral load and pathology. The study indicates blockade of activin signaling may be beneficial in treating COVID-19 patients experiencing ARDS.


Subject(s)
Activins/blood , Antibodies, Monoclonal, Humanized/therapeutic use , COVID-19 Drug Treatment , Follistatin-Related Proteins/blood , SARS-CoV-2/drug effects , Adult , Aged , Animals , Antibodies, Monoclonal, Humanized/administration & dosage , COVID-19/mortality , COVID-19/virology , Cell Line , Cells, Cultured , Cricetinae , Double-Blind Method , Female , Hospitalization/statistics & numerical data , Humans , Male , Middle Aged , Outcome Assessment, Health Care/methods , Outcome Assessment, Health Care/statistics & numerical data , SARS-CoV-2/physiology , Severity of Illness Index , Signal Transduction/drug effects , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...